4//SEC Filing
M33 Growth I L.P. 4
Accession 0001213900-25-046977
CIK 0001799191other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 7:38 PM ET
Size
10.4 KB
Accession
0001213900-25-046977
Insider Transaction Report
Form 4
TOI M, LLC
Director10% Owner
Transactions
- Sale
Common Stock
2025-05-20$2.71/sh−203,532$552,162→ 1,349,048 total(indirect: See Footnote) - Sale
Common Stock
2025-05-20$2.71/sh−1,796,468$4,873,638→ 14,624,233 total
M33 Growth I GP LLC
Director10% Owner
Transactions
- Sale
Common Stock
2025-05-20$2.71/sh−1,796,468$4,873,638→ 14,624,233 total - Sale
Common Stock
2025-05-20$2.71/sh−203,532$552,162→ 1,349,048 total(indirect: See Footnote)
M33 Growth I L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2025-05-20$2.71/sh−1,796,468$4,873,638→ 14,624,233 total - Sale
Common Stock
2025-05-20$2.71/sh−203,532$552,162→ 1,349,048 total(indirect: See Footnote)
Footnotes (2)
- [F1]M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
- [F2]These securities are held by TOI M, LLC.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001718621
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 7:38 PM ET
- Size
- 10.4 KB